192 related articles for article (PubMed ID: 34176466)
1. Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia.
Okawa R; Kokomoto K; Nakano K
BMC Oral Health; 2021 Jun; 21(1):323. PubMed ID: 34176466
[TBL] [Abstract][Full Text] [Related]
2. Effects of Enzyme Replacement Therapy for Primary Teeth in a Patient with Infantile Hypophosphatasia.
Okawa R; Matayoshi S; Kariya R; Ogaya Y; Nomura R; Nakano K
J Clin Pediatr Dent; 2020 Sep; 44(5):348-351. PubMed ID: 33181846
[TBL] [Abstract][Full Text] [Related]
3. Dental defects in the primary dentition associated with hypophosphatasia from biallelic ALPL mutations.
Kramer K; Chavez MB; Tran AT; Farah F; Tan MH; Kolli TN; Dos Santos EJL; Wimer HF; Millán JL; Suva LJ; Gaddy D; Foster BL
Bone; 2021 Feb; 143():115732. PubMed ID: 33160095
[TBL] [Abstract][Full Text] [Related]
4. Dental Manifestations Leading to the Diagnosis of Hypophosphatasia in Two Children.
Okawa R; Kadota T; Matayoshi S; Nakano K
J Dent Child (Chic); 2020 Sep; 87(3):179-183. PubMed ID: 33349304
[TBL] [Abstract][Full Text] [Related]
5. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
Gasque KC; Foster BL; Kuss P; Yadav MC; Liu J; Kiffer-Moreira T; van Elsas A; Hatch N; Somerman MJ; Millán JL
Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia.
McKee MD; Nakano Y; Masica DL; Gray JJ; Lemire I; Heft R; Whyte MP; Crine P; Millán JL
J Dent Res; 2011 Apr; 90(4):470-6. PubMed ID: 21212313
[TBL] [Abstract][Full Text] [Related]
7. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Bowden SA; Foster BL
Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
[TBL] [Abstract][Full Text] [Related]
8. Six-year clinical outcomes of enzyme replacement therapy for perinatal lethal and infantile hypophosphatasia in Korea: Two case reports.
Kim I; Noh ES; Kim MS; Jang JH; Jeon TY; Choi HW; Cho SY
Medicine (Baltimore); 2023 Feb; 102(6):e32800. PubMed ID: 36820543
[TBL] [Abstract][Full Text] [Related]
9. Dental outcomes for children receiving asfotase alfa for hypophosphatasia.
Schroth RJ; Long C; Lee VHK; Alai-Towfigh H; Rockman-Greenberg C
Bone; 2021 Nov; 152():116089. PubMed ID: 34175501
[TBL] [Abstract][Full Text] [Related]
10. Prenatal asfotase alfa-mediated enzyme replacement therapy restores delayed calcification in a severe infantile form of hypophosphatasia model mice.
Yoshida K; Ishizuka S; Nakamura-Takahashi A; Hasegawa A; Umezawa A; Koshika K; Ichinohe T; Kasahara M
Eur J Med Genet; 2023 Jul; 66(7):104787. PubMed ID: 37209904
[TBL] [Abstract][Full Text] [Related]
11. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.
Foster BL; Sheen CR; Hatch NE; Liu J; Cory E; Narisawa S; Kiffer-Moreira T; Sah RL; Whyte MP; Somerman MJ; Millán JL
J Dent Res; 2015 May; 94(5):706-14. PubMed ID: 25716980
[TBL] [Abstract][Full Text] [Related]
12. Conditional Alpl Ablation Phenocopies Dental Defects of Hypophosphatasia.
Foster BL; Kuss P; Yadav MC; Kolli TN; Narisawa S; Lukashova L; Cory E; Sah RL; Somerman MJ; Millán JL
J Dent Res; 2017 Jan; 96(1):81-91. PubMed ID: 27582029
[TBL] [Abstract][Full Text] [Related]
13. Dental manifestation and management of hypophosphatasia.
Okawa R; Nakano K
Jpn Dent Sci Rev; 2022 Nov; 58():208-216. PubMed ID: 35814738
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy improves dental manifestations in hypophosphatasia model mice.
Okawa R; Iijima O; Kishino M; Okawa H; Toyosawa S; Sugano-Tajima H; Shimada T; Okada T; Ozono K; Ooshima T; Nakano K
J Periodontal Res; 2017 Jun; 52(3):471-478. PubMed ID: 27561677
[TBL] [Abstract][Full Text] [Related]
15. A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the
Hacıhamdioğlu B; Özgürhan G; Pereira C; Tepeli E; Acar G; Cömert S
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):306-310. PubMed ID: 30468149
[TBL] [Abstract][Full Text] [Related]
16. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.
Okazaki Y; Kitajima H; Mochizuki N; Kitaoka T; Michigami T; Ozono K
Eur J Pediatr; 2016 Mar; 175(3):433-7. PubMed ID: 26459154
[TBL] [Abstract][Full Text] [Related]
17. Lethal Encephalopathy in an Infant with Hypophosphatasia despite Enzyme Replacement Therapy.
Raimann A; Haberler C; Patsch J; Ertl DA; Sadeghi K; Freilinger M; Lang S; Schmook M; Plecko B; Haeusler G
Horm Res Paediatr; 2021; 94(9-10):390-398. PubMed ID: 34673643
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.
Liu J; Campbell C; Nam HK; Caron A; Yadav MC; Millán JL; Hatch NE
Bone; 2015 Sep; 78():203-11. PubMed ID: 25959417
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D
Kinoshita Y; Mohamed FF; Amadeu de Oliveira F; Narisawa S; Miyake K; Foster BL; Millán JL
J Bone Miner Res; 2021 Sep; 36(9):1835-1849. PubMed ID: 34076297
[TBL] [Abstract][Full Text] [Related]
20. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
Bowden SA; Adler BH
Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
